Rentabilidad en el año
| Fondo | Fecha | |||||
|---|---|---|---|---|---|---|
| 2026 | ||||||
| Resultados por página: 10 | 20 | 50 | 100Se muestran de 1681 a 1690 de un total de 43556 fondos | ||||||
| TELESCOPE BIOTECH FUND, FIL ORO | 30/09 | 23,74% | ||||
| UBS (IRL) INVESTOR SELECTION - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) I-B-ACC | 30/10 | 23,74% | ||||
| AMUNDI FUNDS US EQUITY RESEARCH VALUE G USD (C) | 02/11 | 23,73% | ||||
| EDMOND DE ROTHSCHILD FUND-BIG DATA P EUR CAP | 02/11 | 23,73% | ||||
| AXA IM JAPAN EQUITY B EUR HEDGED ACC | 02/11 | 23,72% | ||||
| DWS CONCEPT NISSAY JAPAN VALUE EQUITY JPY LD | 02/11 | 23,72% | ||||
| MAN JAPAN COREALPHA EQUITY I JPY | 02/11 | 23,72% | ||||
| ROBECO EMERGING STARS EQUITIES DL EUR | 02/11 | 23,72% | ||||
| ALLIANZ JAPAN EQUITY IT (H-EUR) EUR | 02/11 | 23,71% | ||||
| NEUBERGER BERMAN JAPAN EQUITY ENGAGEMENT USD I ACC (HEDGED) | 02/11 | 23,70% | ||||
